H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
SARS-CoV-2 survives on human skin for 9 hours

SARS-CoV-2 survives on human skin for 9 hours

In debate, Pence and Harris offer conflicting views of nation’s reality

In debate, Pence and Harris offer conflicting views of nation’s reality

Study estimates lower herd immunity to SARS-CoV-2 in the U.S.

Study estimates lower herd immunity to SARS-CoV-2 in the U.S.

COVID-19 mortality linked to differences in trust and income inequality

COVID-19 mortality linked to differences in trust and income inequality

Climate anomaly exacerbated WWI mortality and the Spanish flu pandemic

Climate anomaly exacerbated WWI mortality and the Spanish flu pandemic

Researchers examine the impact of human movement on disease spread

Researchers examine the impact of human movement on disease spread

Can amodiaquine short circuit this pandemic?

Can amodiaquine short circuit this pandemic?

Research compares T cell responses to SARS-CoV-2 and influenza

Research compares T cell responses to SARS-CoV-2 and influenza

Dozens of U.S. hospitals poised to defy FDA’s directive on COVID plasma

Dozens of U.S. hospitals poised to defy FDA’s directive on COVID plasma

Health officials worry nation is not ready for COVID-19 vaccine

Health officials worry nation is not ready for COVID-19 vaccine

Silicon nitride shows potent SARS-CoV-2 neutralization capability

Silicon nitride shows potent SARS-CoV-2 neutralization capability

Pigs appear to be immune to SARS-CoV-2

Pigs appear to be immune to SARS-CoV-2

COVID-19 pandemic as severe as 1918 influenza pandemic

COVID-19 pandemic as severe as 1918 influenza pandemic

How have non-pharmaceutical interventions helped in COVID-19?

How have non-pharmaceutical interventions helped in COVID-19?

Study: Drinking honeysuckle decoction accelerates the negative conversion of COVID-19 patients

Study: Drinking honeysuckle decoction accelerates the negative conversion of COVID-19 patients

Humans promote diseases from the animal kingdom

Humans promote diseases from the animal kingdom

Oxford Nanopore Technologies partners with UK Government to roll out LamPORE, a new generation of COVID-19 test

Oxford Nanopore Technologies partners with UK Government to roll out LamPORE, a new generation of COVID-19 test

Meta-analysis shows 57% mortality reduction with convalescent plasma in COVID-19

Meta-analysis shows 57% mortality reduction with convalescent plasma in COVID-19

Scientists develop human lung organoids to study SARS-CoV-2 infection

Scientists develop human lung organoids to study SARS-CoV-2 infection

Antimalarial drug shows in vitro activity against SARS-CoV-2 and flu viruses

Antimalarial drug shows in vitro activity against SARS-CoV-2 and flu viruses

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.